These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1741 related items for PubMed ID: 9861628

  • 1. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [Abstract] [Full Text] [Related]

  • 2. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [Abstract] [Full Text] [Related]

  • 3. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ, Wiśniewski K.
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [Abstract] [Full Text] [Related]

  • 4. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
    Fiedorowicz RJ, Wiśniewski K.
    Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
    [Abstract] [Full Text] [Related]

  • 5. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ, Wiśniewski K.
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [Abstract] [Full Text] [Related]

  • 6. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H, Moribe S, Sato M, Kotani A, Koshikawa N, Cools AR.
    Eur J Pharmacol; 2007 Jan 12; 554(2-3):175-82. PubMed ID: 17113067
    [Abstract] [Full Text] [Related]

  • 7. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
    Wiśniewska RJ, Kupryszewski G.
    Pol J Pharmacol Pharm; 1992 Jan 12; 44(3):281-7. PubMed ID: 1470565
    [Abstract] [Full Text] [Related]

  • 8. The central action of drugs influencing beta-adrenergic receptor. part V. The interaction of drugs affecting beta-adrenergic receptor in motility test.
    Ksiaz A, Kleinrok Z.
    Pol J Pharmacol Pharm; 1975 Jan 12; 27(6):595-601. PubMed ID: 1714
    [Abstract] [Full Text] [Related]

  • 9. Effect of beta-adrenoceptors on the behaviour induced by the neuropeptide glutamic acid isoleucine amide.
    Sánchez-Borzone ME, Attademo A, Baiardi G, Celis ME.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):186-91. PubMed ID: 17537427
    [Abstract] [Full Text] [Related]

  • 10. The influence of the adrenergic drugs on the electrical responses of the rabbit isolated heart atrium.
    Smejkal V, Mironneau J, Ojeda C, Gargouil YM.
    Physiol Bohemoslov; 1970 Jul 30; 19(1):19-22. PubMed ID: 4394505
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular effects of tyramine: adrenergic and cholinergic interactions.
    Khwanchuea R, Mulvany MJ, Jansakul C.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):308-17. PubMed ID: 18036584
    [Abstract] [Full Text] [Related]

  • 12. [Effects of alpha and beta blocker properties of parahydroxybenzonitrile on the cardiovascular system of rats].
    Cheav SL, Kirkiacharian S, Piéri F, Poisson D.
    Ann Pharm Fr; 1998 Jan 28; 56(5):205-8. PubMed ID: 9805819
    [Abstract] [Full Text] [Related]

  • 13. Effects of autonomic blockade on non-linear cardiovascular variability indices in rats.
    Beckers F, Verheyden B, Ramaekers D, Swynghedauw B, Aubert AE.
    Clin Exp Pharmacol Physiol; 2006 Jan 28; 33(5-6):431-9. PubMed ID: 16700875
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
    Mutafova-Yambolieva V, Staneva-Stoytcheva D.
    Methods Find Exp Clin Pharmacol; 1988 Sep 28; 10(9):551-7. PubMed ID: 2906393
    [Abstract] [Full Text] [Related]

  • 15. Catecholaminergic regulation of the hypothalamic-pituitary-adrenocortical activity.
    Bugajski J, Turoń M, Gadek-Michalska A, Borycz JA.
    J Physiol Pharmacol; 1991 Mar 28; 42(1):93-103. PubMed ID: 1681965
    [Abstract] [Full Text] [Related]

  • 16. Involvement of beta-adrenoceptors in a central regulation of the ovarian progesterone release in rats.
    De Bortoli MA, Garraza MH, Aguado LI.
    Neuro Endocrinol Lett; 2002 Feb 28; 23(1):27-31. PubMed ID: 11880859
    [Abstract] [Full Text] [Related]

  • 17. Functional involvement of vasopressin in the maintenance of systemic arterial blood pressures after phenoxybenzamine or phentolamine administration: studies in Long-Evans and Brattleboro rats.
    Winn MJ, Gardiner SM, Bennett T.
    J Pharmacol Exp Ther; 1985 Nov 28; 235(2):500-5. PubMed ID: 2865355
    [Abstract] [Full Text] [Related]

  • 18. Neurotransmitter-mediated control of neuronal firing in the red nucleus of the rat: reciprocal modulation between noradrenaline and GABA.
    Ciranna L, Licata F, Li Volsi G, Santangelo F.
    Exp Neurol; 2000 May 28; 163(1):253-63. PubMed ID: 10785465
    [Abstract] [Full Text] [Related]

  • 19. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J, Zhang LF, Han C, Yu GS, Ma J.
    J Gravit Physiol; 1996 Apr 28; 3(1):57-62. PubMed ID: 11539308
    [Abstract] [Full Text] [Related]

  • 20. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.
    Armour JA.
    Can J Cardiol; 1997 Mar 28; 13(3):277-84. PubMed ID: 9117916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.